We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Investigator Gets Warning Letter for Lapsed IRB Approval
Investigator Gets Warning Letter for Lapsed IRB Approval
December 30, 2009
A clinical investigator has received a warning letter from the FDA for not properly randomizing trial subjects and for performing research activities after approval by the institutional review board (IRB) had expired.